Condensed Statements of Cash Flows (Unaudited) - USD ($)		9 Months Ended
		Sep. 30, 2021	Sep. 30, 2020
Cash Flows from Operating Activities:
Net income (loss)		$ 4,638,019	$ (491,238)	[1],[2]
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(44,344)	(2,426)	[2]
Change in fair value of derivative warrant liability		(5,143,432)		[2]
Offering cost associated with warrants recorded as liabilities			379,848	[2]
Changes in operating assets and liabilities
Prepaid expenses		123,501	(37,429)	[2]
Accrued expenses		(8,279)	110,525	[2]
Net cash used in operating activities		(434,535)	(40,720)	[2]
Cash Flows from Investing Activities:
Proceeds from maturity of securities in Trust Account		175,073,579		[2]
Investment of cash in Trust Account		(175,073,579)	(175,000,000)	[2]
Net cash used in investing activities			(175,000,000)	[2]
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid			171,500,000	[2]
Proceeds from sale of Founder Shares			25,000	[2]
Proceeds from sale of Private Warrants			6,150,000	[2]
Proceeds from promissory note – related party			150,000	[2]
Proceeds from underwriter’s rebate			175,000	[2]
Payment of offering costs			(124,310)	[2]
Net cash provided by financing activities			177,875,690	[2]
Net Increase (Decrease) in Cash		(434,535)	2,834,970	[2]
Cash and cash equivalents – Beginning of period		2,005,228		[2]
Cash and cash equivalents – End of period		$ 1,570,693	2,834,970	[2]
Non-cash investing and financing activities:
Initial classification of common stock subject to possible redemption	[2]		175,000,000
Offering costs included in accrued offering costs	[2]		383,080
Deferred underwriting fee payable	[2]		$ 6,125,000

[1] For the period from March 18, 2020 (inception) through September 30, 2020

[2] For the period from March 18, 2020 (inception) through September 30, 2020